Emerging utility of once-weekly exenatide in patients with type 2 diabetes
Aditya Goud, Jixin Zhong, Sanjay RajagopalanDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland, Baltimore, MD, USAAbstract: Type 2 diabetes mellitus (T2DM) is a major risk factor for the development of cardiovascular disease (CVD). Due to the ever increasing incidenc...
Main Authors: | Goud A, Zhong J, Rajagopalan S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | https://www.dovepress.com/emerging-utility-of-once-weekly-exenatide-in-patients-with-type-2-diab-peer-reviewed-article-DMSO |
Similar Items
-
Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
by: Inaishi J, et al.
Published: (2022-02-01) -
EXSCEL—once-weekly exenatide reduces medical resource utilization in patients with type 2 diabetes mellitus
by: Reed, S, et al.
Published: (2018) -
Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
by: Yuusuke Watanabe, et al.
Published: (2020-03-01) -
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
by: Mann KV, et al.
Published: (2014-06-01) -
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Seewoodhary J, et al.
Published: (2010-05-01)